AbbVie Inc.

Healthcare · Drug Manufacturers - General · United States

Last price 294.89 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 521.11B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medi...